Join
Live feed
·
INSIDERFilingvia Quantisnow
Qualigen Therapeutics Inc. logo

SEC Form 4: Poirier Michael S. bought $17,100 worth of shares (30,000 units at $0.57), increasing direct ownership by 18% to 199,202 units

ByQuantisnow·Wall Street's wire, on your screen.
QLGN· Qualigen Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track QLGN (Qualigen Therapeutics Inc.) and more on Quantisnow.